As another new year gets under way many of us will be looking for a way of boosting how we feel but is it better to hit the ...
The press release promoting the study asserts that “universal SEL programs are a sound investment in education systems ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milkNorovirus-specific ...
Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify Our guest on the ...
John Holmes and colleagues argue for a precautionary approach that is guided by public health interests and considers both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback